Your browser doesn't support javascript.
loading
Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid Cancer: Efficacy, Safety, and Survival Predictors.
Liu, Qingxing; Kulkarni, Harshad R; Zhao, Tianzhi; Schuchardt, Christiane; Chen, Xiaoyuan; Zhu, Zhaohui; Zhang, Jingjing; Baum, Richard P.
Afiliação
  • Kulkarni HR; THERANOSTICS Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Schuchardt C; THERANOSTICS Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Zhu Z; From the Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing.
  • Baum RP; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.
Clin Nucl Med ; 48(3): 221-227, 2023 Mar 01.
Article em En | MEDLINE | ID: mdl-36723881
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Neoplasias da Glândula Tireoide / Tumores Neuroendócrinos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Nucl Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Neoplasias da Glândula Tireoide / Tumores Neuroendócrinos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Nucl Med Ano de publicação: 2023 Tipo de documento: Article